Sergio
Ruiz Llorente
Profesor/a Ayudante Doctor/a
Charité
Berlín, AlemaniaPublications in collaboration with researchers from Charité (1)
2022
-
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
Virchows Archiv, Vol. 480, Núm. 4, pp. 855-871